⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8763359 | 0.77 | ALDH1A1 (0.38) | — | |
| SCHEMBL8762363 | 0.77 | — | — | |
| SCHEMBL20183952 | 0.75 | — | — | |
| SCHEMBL11739183 | 0.72 | — | — | |
| SCHEMBL11739177 | 0.72 | — | — | |
| SCHEMBL17163000 | 0.72 | — | — | |
| SCHEMBL11730186 | 0.72 | ALDH1A1 (0.33) | — | |
| SCHEMBL11339733 | 0.70 | TRPA1 (0.35) | — | |
| SCHEMBL8180909 | 0.69 | ALDH1A1 (0.32) | — | |
| SCHEMBL8764127 | 0.69 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 892 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084759-A1 | FLUORESCENT DYE OIL TRACER COMPOSITIONS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-03-13 | — | — | US | claimed |
| CN-113717126-B | Buprofezin medicament for killing insects and production process thereof | 安徽广信农化股份有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-111450857-B | Catalyst and preparation process of tert-butyl isothiocyanate | 江苏帕睿尼新材料科技有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-112844472-B | Preparation method and application of chiral imidazole urea catalyst | 深圳市宝安区新材料研究院 | 2023-05-23 | — | — | CN | claimed |
| CN-115704808-A | Headspace solid phase microextraction-gas chromatography mass spectrometry detection and analysis method | 丰益(上海)生物技术研发中心有限公司 | 2023-02-17 | — | — | CN | claimed |
| CN-115483370-A | High-energy-density super low-temperature lithium iron phosphate power battery | 勤正科技(苏州)有限公司 | 2022-12-16 | — | — | CN | claimed |
| EP-3681476-B1 | TRANSDERMAL FORMULATIONS | TYME INC (US) | 2022-09-14 | — | — | EP | claimed |
| CN-114573487-A | Method for preparing butylpropylthiourea | 南京先进生物材料与过程装备研究院有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-113751205-A | N-tert-butyl ester collecting agent and preparation method thereof | 紫金矿业集团股份有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-113717126-A | Buprofezin medicament for killing insects and production process thereof | 安徽广信农化股份有限公司 | 2021-11-30 | — | — | CN | claimed |
| US-20030166646-A1 | Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase | AVENTIS PHARMA S.A. (FR) | 2003-09-04 | — | — | US | claimed |
| US-20030153605-A1 | Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase | AVENTIS PHARMA S.A. (FR) | 2003-08-14 | — | — | US | claimed |
| WO-2003040115-A1 | 2-AMINO-THIAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF INDUCIBLE NO-SYNTHASE | AVENTIS PHARMA S.A. (FR) | 2003-05-15 | — | — | WO | claimed |
| WO-2003039446-A2 | USE OF 2-AMINO-4-PYRIDYLMETHYL-THIAZOLINE DERIVATIVES AS INHIBITORS OF INDUCIBLE NO-SYNTHASE | AVENTIS PHARMA S.A. (FR) | 2003-05-15 | — | — | WO | claimed |
| WO-2003040142-A1 | 2-AMINO-4-HETEROARYLETHYL THIAZOLINE DERIVATIVES AND THEIR USE AN INHIBITORS OF INDUCIBLE NO-SYNTHASE | AVENTIS PHARMA S.A. (FR) | 2003-05-15 | — | — | WO | claimed |
| US-20020128512-A1 | Thiol- modified hyaluronan | ANIKA THERAPEUTICS, INC. | 2002-09-12 | — | — | US | claimed |
| WO-2002068383-A2 | THIOL-MODIFIED HYALURONAN | ANIKA THERAPEUTICS, INC. (US) | 2002-09-06 | — | — | WO | claimed |
| WO-1992013530-A1 | TRANSGLUTAMINASE ENZYME INHIBITORS | MEDICIS CORPORATION (US) | 1992-08-20 | — | — | WO | claimed |
| CN-87103808-A | The dopamine-inhibitor | — | 1987-12-09 | — | — | CN | claimed |
| EP-0246888-A2 | Dopamine-beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1987-11-25 | — | — | EP | claimed |